L50.5 Pressure Urticaria – Causes, Symptoms & Treatment
L50.5 is the ICD-10 code for pressure urticaria, a skin condition in which sustained pressure on the skin triggers wheals and swelling. It belongs to the group of physical urticarias.
Things worth knowing about "L50.5"
L50.5 is the ICD-10 code for pressure urticaria, a skin condition in which sustained pressure on the skin triggers wheals and swelling. It belongs to the group of physical urticarias.
What is L50.5 – Pressure Urticaria?
L50.5 is the official ICD-10 diagnosis code for pressure urticaria, also referred to as delayed pressure urticaria (DPU). It is a form of physical urticaria in which sustained mechanical pressure applied to the skin triggers a characteristic delayed inflammatory reaction. Unlike immediate urticarial responses, symptoms in pressure urticaria typically appear several hours after the pressure stimulus has been applied.
Causes and Triggers
The exact pathophysiology of pressure urticaria is not yet fully understood. It is believed that mechanical pressure activates mast cells in the skin and subcutaneous tissue, leading to the release of histamine and other inflammatory mediators. Common triggers include:
- Tight footwear or clothing (e.g., waistbands, bra straps)
- Prolonged sitting or standing on hard surfaces
- Carrying heavy bags or backpacks
- Repetitive gripping or use of tools
- Sports or physical activities involving sustained pressure
Contributing factors may include stress, infections, certain medications, or an underlying chronic urticaria condition.
Symptoms
Typical symptoms of pressure urticaria (L50.5) include:
- Wheals and swellings at the sites of pressure application, usually appearing 3–12 hours after the pressure stimulus
- Deep, painful swellings in the subcutaneous tissue (angioedema), similar to those seen in Quincke's edema
- Itching, burning, or a feeling of tension in the affected area
- General malaise, and occasionally fatigue or mild fever
- Symptoms that may persist for several hours to up to two days
Diagnosis
Diagnosis of pressure urticaria is primarily clinical, based on a detailed medical history and a standardized pressure test. A defined weight (e.g., 2.5 kg) is placed on the shoulder or thigh for 15–20 minutes, and a positive response (wheal or deep swelling) is expected within 30 minutes to 8 hours after stimulation.
Additional diagnostic steps may include:
- Blood tests to rule out underlying conditions
- Allergy testing if an allergic component is suspected
- Differential diagnosis to exclude other forms of urticaria (e.g., symptomatic dermographism, cold or heat urticaria)
Treatment
Treatment of L50.5 depends on the severity of the condition. Key therapeutic options include:
General Measures
- Avoidance of sustained pressure, for example by wearing soft footwear, loose clothing, or using pressure-relief padding
- Adaptation of daily activities and occupational routines
Pharmacological Therapy
- Second-generation antihistamines (e.g., cetirizine, loratadine) as first-line therapy – often required at higher-than-standard doses
- Omalizumab (a monoclonal anti-IgE antibody) for severe, antihistamine-resistant cases – approved for chronic spontaneous urticaria and used in practice for pressure urticaria as well
- Corticosteroids may be used short-term during acute episodes but are not suitable for long-term management
- Dapsone or other immunomodulatory agents in refractory cases (off-label use)
Prognosis and Course
Pressure urticaria is often a chronic condition that can significantly impact quality of life. In many cases the condition can be well controlled with appropriate treatment, and spontaneous remission is possible but not common. Regular follow-up with a dermatologist or allergologist is recommended.
References
- Magerl M. et al. – S3 Guideline Urticaria, Deutsche Dermatologische Gesellschaft (DDG) / European Academy of Allergology and Clinical Immunology (EAACI), 2022.
- Zuberbier T. et al. – The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy, 2022; 77(3): 734–766.
- World Health Organization – ICD-10 International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Code L50.5.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryMost read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: L50.5